Walgreens Boots Alliance, Inc. (NASDAQ:WBA) Shares Purchased by United Capital Financial Advisers LLC

United Capital Financial Advisers LLC boosted its holdings in Walgreens Boots Alliance, Inc. (NASDAQ:WBAGet Rating) by 5.4% during the 2nd quarter, according to the company in its most recent disclosure with the SEC. The fund owned 144,336 shares of the pharmacy operator’s stock after buying an additional 7,339 shares during the quarter. United Capital Financial Advisers LLC’s holdings in Walgreens Boots Alliance were worth $5,470,000 as of its most recent SEC filing.

Several other hedge funds have also recently added to or reduced their stakes in WBA. GoalVest Advisory LLC grew its position in Walgreens Boots Alliance by 10,828.6% in the second quarter. GoalVest Advisory LLC now owns 765 shares of the pharmacy operator’s stock worth $29,000 after buying an additional 758 shares during the last quarter. WFA of San Diego LLC purchased a new position in Walgreens Boots Alliance during the 2nd quarter worth approximately $32,000. Tompkins Financial Corp grew its position in Walgreens Boots Alliance by 215.7% during the 1st quarter. Tompkins Financial Corp now owns 947 shares of the pharmacy operator’s stock worth $42,000 after purchasing an additional 647 shares in the last quarter. Baystate Wealth Management LLC grew its position in Walgreens Boots Alliance by 209.4% during the 2nd quarter. Baystate Wealth Management LLC now owns 1,216 shares of the pharmacy operator’s stock worth $46,000 after purchasing an additional 823 shares in the last quarter. Finally, CX Institutional purchased a new position in Walgreens Boots Alliance during the 2nd quarter worth approximately $47,000. Institutional investors and hedge funds own 57.33% of the company’s stock.

Wall Street Analysts Forecast Growth

Several equities analysts have weighed in on WBA shares. Morgan Stanley reiterated an “underweight” rating and set a $39.00 price objective on shares of Walgreens Boots Alliance in a research report on Wednesday. Royal Bank of Canada lowered their price objective on shares of Walgreens Boots Alliance from $42.00 to $36.00 and set a “sector perform” rating on the stock in a research report on Wednesday, October 19th. Mizuho lowered their price objective on shares of Walgreens Boots Alliance to $36.00 in a research report on Thursday, October 13th. UBS Group lowered their price objective on shares of Walgreens Boots Alliance from $40.00 to $37.00 and set a “neutral” rating on the stock in a research report on Friday, October 7th. Finally, Credit Suisse Group lowered their price objective on shares of Walgreens Boots Alliance from $43.00 to $42.00 and set a “neutral” rating on the stock in a research report on Friday, October 14th. One equities research analyst has rated the stock with a sell rating, nine have issued a hold rating and four have given a buy rating to the company’s stock. Based on data from MarketBeat.com, Walgreens Boots Alliance presently has a consensus rating of “Hold” and a consensus price target of $43.23.

Walgreens Boots Alliance Stock Down 0.1 %

WBA stock opened at $41.76 on Thursday. The company has a current ratio of 0.75, a quick ratio of 0.38 and a debt-to-equity ratio of 0.36. Walgreens Boots Alliance, Inc. has a 1 year low of $30.39 and a 1 year high of $55.00. The company has a fifty day simple moving average of $35.22 and a 200 day simple moving average of $38.10. The firm has a market cap of $36.11 billion, a PE ratio of 8.35, a PEG ratio of 1.86 and a beta of 0.71.

Walgreens Boots Alliance (NASDAQ:WBAGet Rating) last released its quarterly earnings data on Thursday, October 13th. The pharmacy operator reported $0.80 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.77 by $0.03. Walgreens Boots Alliance had a net margin of 3.27% and a return on equity of 14.39%. The business had revenue of $32.45 billion during the quarter, compared to analyst estimates of $32.17 billion. During the same quarter in the previous year, the business earned $1.17 EPS. Walgreens Boots Alliance’s quarterly revenue was down 5.3% compared to the same quarter last year. Sell-side analysts anticipate that Walgreens Boots Alliance, Inc. will post 4.5 EPS for the current fiscal year.

Walgreens Boots Alliance Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Monday, December 12th. Investors of record on Tuesday, November 15th will be paid a $0.48 dividend. This represents a $1.92 annualized dividend and a dividend yield of 4.60%. The ex-dividend date is Monday, November 14th. Walgreens Boots Alliance’s payout ratio is presently 38.40%.

Insider Activity at Walgreens Boots Alliance

In related news, Director Nancy M. Schlichting sold 16,570 shares of Walgreens Boots Alliance stock in a transaction on Thursday, November 17th. The shares were sold at an average price of $39.89, for a total value of $660,977.30. Following the completion of the sale, the director now owns 5,515 shares of the company’s stock, valued at approximately $219,993.35. The transaction was disclosed in a document filed with the SEC, which can be accessed through the SEC website. In other Walgreens Boots Alliance news, Director Nancy M. Schlichting sold 16,570 shares of the business’s stock in a transaction on Thursday, November 17th. The shares were sold at an average price of $39.89, for a total transaction of $660,977.30. Following the completion of the transaction, the director now owns 5,515 shares of the company’s stock, valued at approximately $219,993.35. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, EVP Kevin M. Ban sold 10,303 shares of the business’s stock in a transaction on Friday, November 18th. The stock was sold at an average price of $40.19, for a total transaction of $414,077.57. Following the transaction, the executive vice president now directly owns 27,916 shares of the company’s stock, valued at approximately $1,121,944.04. The disclosure for this sale can be found here. 17.40% of the stock is owned by company insiders.

About Walgreens Boots Alliance

(Get Rating)

Walgreens Boots Alliance, Inc operates as an integrated healthcare, pharmacy, and retailer in the United States (U.S.), the United Kingdom, Germany, and internationally. It operates through three segments: U.S. Retail Pharmacy, International, and U.S. Healthcare. The U.S. Retail Pharmacy segment sells prescription drugs and an assortment of retail products, including health, wellness, beauty, personal care, consumable, and general merchandise products through its retail drugstores.

Featured Articles

Want to see what other hedge funds are holding WBA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Walgreens Boots Alliance, Inc. (NASDAQ:WBAGet Rating).

Institutional Ownership by Quarter for Walgreens Boots Alliance (NASDAQ:WBA)

Receive News & Ratings for Walgreens Boots Alliance Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Walgreens Boots Alliance and related companies with MarketBeat.com's FREE daily email newsletter.